We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
Turnover
16.03%
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
5.4
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
501
InterDigital
IDCC
$8.33B
| $14.4M | 0.03% |
64,034
+329
| +0.5% | +$69.7K |
2024 Q1
5 quarters
|
|
502
ConocoPhillips
COP
$171B
| $14.1M | 0.03% |
157,665
-81,331
| -34% | -$7.32M |
2013 Q2
48 quarters
|
|
503
CarGurus
CARG
$2.71B
| $14M | 0.03% |
417,801
+7,597
| +2% | +$229K |
2020 Q2
20 quarters
|
|
504
Lumen Technologies, Inc. Common Stock
LUMN
$4.8B
| $14M | 0.03% |
3,186,562
+1,286,085
| +68% | +$4.98M |
2013 Q2
48 quarters
|
|
505
DELISTED
Forte Biosciences
FBRX
| $13.9M | 0.03% |
+1,072,233
| New | +$9.23M |
2025 Q2
0 quarters
|
|
506
Nu Holdings
NU
$72.1B
| $13.8M | 0.03% |
1,006,366
-207,617
| -17% | -$2.49M |
2023 Q2
8 quarters
|
|
507
PPG Industries
PPG
$23.9B
| $13.8M | 0.03% |
121,050
-176,125
| -59% | -$19M |
2013 Q2
48 quarters
|
|
508
Alcoa
AA
$10.6B
| $13.8M | 0.03% |
465,971
+12,401
| +3% | +$335K |
2019 Q3
23 quarters
|
|
509
Vertiv
VRT
$80.1B
| $13.6M | 0.03% |
106,119
-1,016,917
| -91% | -$98.9M |
2023 Q1
9 quarters
|
|
510
W.W. Grainger
GWW
$61.9B
| $13.6M | 0.03% |
13,030
+4,910
| +60% | +$5.1M |
2013 Q2
48 quarters
|
|
511
Life Time Group Holdings
LTH
$9.13B
| $13.5M | 0.03% |
446,044
+121,664
| +38% | +$3.61M |
2024 Q3
3 quarters
|
|
512
AMN Healthcare
AMN
$1.52B
| $13.5M | 0.03% |
651,409
+491,454
| +307% | +$10.2M |
2013 Q2
48 quarters
|
|
513
Methode Electronics
MEI
$500M
| $13.5M | 0.03% |
1,414,441
+629
| +0% | +$4.62K |
2023 Q4
6 quarters
|
|
514
Otter Tail
OTTR
$3.77B
| $13.2M | 0.02% |
171,526
-9,914
| -5% | -$774K |
2019 Q2
24 quarters
|
|
515
Cboe Global Markets
CBOE
$32.2B
| $13.2M | 0.02% |
56,551
-2,079
| -4% | -$463K |
2018 Q4
26 quarters
|
|
516
Astera Labs
ALAB
$49.8B
| $13.1M | 0.02% |
145,000
| – | – |
2024 Q4
2 quarters
|
|
517
Byline Bancorp
BY
$1.67B
| $13.1M | 0.02% |
488,237
+2,084
| +0.4% | +$53.5K |
2021 Q3
15 quarters
|
|
518
Owens Corning
OC
$8.95B
| $12.9M | 0.02% |
94,112
-1,753
| -2% | -$242K |
2019 Q3
23 quarters
|
|
519
Bath & Body Works
BBWI
$4.07B
| $12.9M | 0.02% |
430,024
+405,158
| +1,629% | +$11.9M |
2025 Q1
1 quarter
|
|
520
Sprinklr
CXM
$1.36B
| $12.8M | 0.02% |
1,510,162
-164,001
| -10% | -$1.31M |
2023 Q2
8 quarters
|
|
521
Yext
YEXT
$702M
| $12.7M | 0.02% |
1,489,397
-938,537
| -39% | -$6.58M |
2021 Q4
14 quarters
|
|
522
AvePoint
AVPT
$3.11B
| $12.6M | 0.02% |
654,772
-252,162
| -28% | -$4.37M |
2022 Q4
10 quarters
|
|
523
Trustmark
TRMK
$2.6B
| $12.5M | 0.02% |
343,945
+2,018
| +0.6% | +$69.1K |
2023 Q3
7 quarters
|
|
524
SAP
SAP
$260B
| $12.5M | 0.02% |
41,070
-11,057
| -21% | -$3.17M |
2013 Q2
48 quarters
|
|
525
SiriusPoint
SPNT
$2.92B
| $12.3M | 0.02% |
600,985
+186,493
| +45% | +$3.43M |
2023 Q2
8 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.